CNBS:NYE-Amplify Seymour Cannabis ETF (USD)

ETF | Others |

Last Closing

USD 17.286

Change

-0.87 (-4.81)%

Market Cap

USD 0.06B

Volume

6.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.03 (+0.17%)

USD 65.72B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 40.47B
JEPI JPMorgan Equity Premium Income..

+0.11 (+0.20%)

USD 36.19B
JPST JPMorgan Ultra-Short Income ET..

+0.04 (+0.08%)

USD 31.44B
DFAC Dimensional U.S. Core Equity 2..

+0.08 (+0.25%)

USD 29.60B
DTB DTE Energy Company 2020 Series

-0.06 (-0.34%)

USD 26.58B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 21.14B
GBTC Grayscale Bitcoin Trust (BTC)

-0.53 (-0.70%)

USD 16.17B
CGDV Capital Group Dividend Value E..

+0.07 (+0.20%)

USD 14.38B
AVUV Avantis® U.S. Small Cap Value..

+0.39 (+0.47%)

USD 13.13B

ETFs Containing CNBS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 743.22% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 743.22% 100% F 100% F
Trailing 12 Months  
Capital Gain 236.96% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 236.96% 100% F 100% F
Trailing 5 Years  
Capital Gain 71.65% 69% C- 70% C-
Dividend Return 1.00% 6% D- 2% F
Total Return 72.66% 61% D- 62% D
Average Annual (5 Year Horizon)  
Capital Gain -5.16% 10% F 13% F
Dividend Return -5.16% 7% C- 10% F
Total Return 0.00% N/A F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 76.21% 3% F 10% F
Risk Adjusted Return -6.77% 21% F 19% F
Market Capitalization 0.06B 51% F 23% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.